Yahoo
OTC Markets OTCPK - Delayed Quote USD

Sonova Holding AG (SONVY)

68.74 +0.49 (+0.72%)
At close: October 30 at 4:00:00 PM EDT
Chart Range Bar
Loading chart for SONVY
  • Previous Close 68.25
  • Open 68.81
  • Bid 68.54 x 10000
  • Ask 68.70 x 20000
  • Day's Range 68.62 - 69.14
  • 52 Week Range 42.26 - 69.19
  • Volume 2,633
  • Avg. Volume 20,564
  • Market Cap (intraday) 20.417B
  • Beta (5Y Monthly) 1.08
  • PE Ratio (TTM) 30.83
  • EPS (TTM) 2.23
  • Earnings Date --
  • Forward Dividend & Yield 1.16 (1.69%)
  • 1y Target Est 70.00
  • Zacks Rating Neutral

Sonova Holding AG manufactures and sells hearing care solutions for children and adults in Switzerland, the United States, rest of the Americas, Europe, the Middle East, Africa, and the Asia Pacific. It operates through Hearing Instruments, Cochlear Implants, and Lifestyle-Aligned segments. The Hearing Instruments segment engages in the design, development, manufacture, distribution, and service of hearing instruments and related products, as well as wireless headsets, speech-enhanced hearables, and audiophile headphones under the Phonak, Unitron, Hansaton, and Sennheiser brand names; and audiological care services under the AudioNova, Audition Santé, Boots Hearingcare, Connect Hearing, Geers, Hansaton, Lapperre, Schoonenberg, and Triton Hearing brands. The Cochlear Implants segment is involved in the design, development, manufacture, distribution, and service of hearing instruments and related products under the Advanced Bionics brand. The Lifestyle-Aligned segment designs connected solutions and integrating AI and digital capabilities. It sells its products directly to end consumers through its own store network; wholesales to independent audiologists, third party retail chains, and multinational and government customers; and provides hearing care services through a network of stores and clinics. The company was formerly known as Phonak Holding AG and changed its name to Sonova Holding AG in August 2007. Sonova Holding AG was founded in 1947 and is headquartered in Stäfa, Switzerland.

www.sonova.com

18,570

Full Time Employees

March 31

Fiscal Year Ends

Healthcare

Sector

Medical Devices

Industry

Recent News

View More

Performance Overview

Trailing total returns as of 10/30/2026, which may include dividends or other distributions. Benchmark is MSCI WORLD (^990100-USD-STRD) .

YTD Return

SONVY
31.69%
MSCI WORLD (^990100-USD-STRD)
9.06%

1-Year Return

SONVY
23.86%
MSCI WORLD (^990100-USD-STRD)
9.89%

3-Year Return

SONVY
54.06%
MSCI WORLD (^990100-USD-STRD)
0.00%

5-Year Return

SONVY
11.39%
MSCI WORLD (^990100-USD-STRD)
53.16%

Analyst Insights

View More

Analyst Price Targets

70.00
70.00 Average
68.74 Current
70.00 High

Analyst Recommendations

  • Strong Buy
  • Buy
  • Hold
  • Underperform
  • Sell

Latest Rating

Date 10/31/2019
Analyst Goldman Sachs
Rating Action Downgrade
Rating Sell
Price Action --
Price Target --

Statistics

View More

Valuation Measures

Annual
  • Market Cap

  • Enterprise Value

  • Trailing P/E

  • Forward P/E

  • PEG Ratio (current)

  • Price/Sales (ttm)

  • Price/Book (mrq)

  • Enterprise Value/Revenue

  • Enterprise Value/EBITDA

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    11.94%

  • Return on Assets (ttm)

    7.63%

  • Return on Equity (ttm)

    20.52%

  • Revenue (ttm)

    3.61B

  • Net Income Avi to Common (ttm)

    537.1M

  • Diluted EPS (ttm)

    2.23

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    722M

  • Total Debt/Equity (mrq)

    64.94%

  • Levered Free Cash Flow (ttm)

    346.06M

Company Insights

Research Reports

View More

People Also Watch

Mobilize your Website
View Site in Mobile | Classic
Share by: